This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease
Stem Cell Research & Therapy Open Access 18 December 2023
-
A model study for the manufacture and validation of clinical-grade deciduous dental pulp stem cells for chronic liver fibrosis treatment
Stem Cell Research & Therapy Open Access 25 March 2020
-
Challenges in the translation and commercialization of cell therapies
BMC Biotechnology Open Access 07 August 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allison, M. Genzyme backs Osiris, despite Prochymal flop. Nat Biotechnol 27, 966–967 (2009). https://doi.org/10.1038/nbt1109-966
Issue Date:
DOI: https://doi.org/10.1038/nbt1109-966
This article is cited by
-
Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease
Stem Cell Research & Therapy (2023)
-
A model study for the manufacture and validation of clinical-grade deciduous dental pulp stem cells for chronic liver fibrosis treatment
Stem Cell Research & Therapy (2020)
-
Interactions between mesenchymal stem cells and the immune system
Cellular and Molecular Life Sciences (2017)
-
Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis
Journal of Molecular Neuroscience (2016)
-
Challenges in the translation and commercialization of cell therapies
BMC Biotechnology (2015)